Pyxis Oncology, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Pyxis Oncology, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q1 2024.
  • Pyxis Oncology, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $12.8M, a 5.05% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $12.8M -$680K -5.05% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $12.9M -$660K -4.85% Dec 31, 2023 10-Q 2024-05-14
Q3 2023 $13.1M -$1.57M -10.7% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $13.3M -$1.72M -11.5% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $13.5M -$1.84M -12% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $13.6M +$13.4M +5763% Dec 31, 2022 10-K 2024-03-21
Q3 2022 $14.7M +$14.3M +3688% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $15M Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $15.3M Apr 1, 2022 10-K 2023-03-22
Q4 2021 $232K -$604K -72.2% Dec 31, 2021 10-K 2023-03-22
Q3 2021 $388K Sep 30, 2021 10-Q 2021-11-15
Q4 2020 $836K Dec 31, 2020 10-K 2022-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.